Dr. Susan Burgin, MD

Dr. Burgin practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Burgin's NPI, 1174580906, was assigned on April 26, 2006. Dr. Burgin graduated from University of the Witwatersrand in 1990. Dr. Burgin holds Massachusetts license 226109.

Dr. Burgin's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Burgin's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Burgin to 3 more group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burgin practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Burgin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Burgin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Burgin's licenses on file in 2 states: Massachusetts and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Burgin treats.

CMS data shows 2,592 Medicare services from Dr. Burgin across 11 procedure codes in 2024, for 563 Medicare patients. Medicare paid $122,123 for them. Every service was in an office.

CMS counts 563 Medicare patients who saw Dr. Burgin in 2024. The largest group is 65 to 74, with 248 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Burgin's median patient age at 73, with 78% women.

In 2024, Dr. Burgin wrote 967 Medicare Part D claims for 351 patients. 95% of them were for generic drugs. CMS names the drug for 825 of them, across 21 drugs with 11 or more claims each, at $74,996 in total drug cost. In 2023, CMS named 652 claims across 22 drugs.

Dr. Burgin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 739 procedures of removal of skin lesions by Dr. Burgin, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 41 papers to Dr. Burgin, published from 2011 to 2022. 2017 was the busiest year, with 5. The most frequent topics are Dermatology, Skin and Skin Diseases. Dr. Burgin has published most often in Int J Dermatol. Dr. Burgin's most frequent co-authors are Jasmine Kaur Rana, MD, Lawrence Charles Parish, MD and Connie Shi, MD.

Dmand AI links Dr. Burgin to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous.

CMS Open Payments shows 1 general payment to Dr. Burgin from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $19.

Dmand AI lists 2 awards for Dr. Burgin, most recently CMS Stage 1 2012 in 2012.

Dr. Burgin graduated from University of the Witwatersrand in 1990. Dr. Burgin is a member of AAD.

Dr. Burgin is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.